QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)
QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)
QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)
QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.15
+3.6%
$1.21
$0.84
$2.03
$43.85M0.99122,052 shs82,903 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
C$12.28
+0.3%
C$11.54
C$9.59
C$13.72
C$2.55B2.85423,315 shs179,146 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-3.48%-11.20%-2.63%-9.02%-26.49%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
+0.99%-3.47%+5.79%+14.07%+3.55%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.545 of 5 stars
3.50.00.00.00.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
3.5657 of 5 stars
3.40.01.70.01.82.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00508.70% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
2.78
Moderate BuyC$14.8120.57% Upside

Current Analyst Ratings

Latest NVA, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperformC$17.00
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
3/22/2024
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuyC$15.00 ➝ C$14.75
3/4/2024
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$14.25 ➝ C$14.50
3/1/2024
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$15.00 ➝ C$15.50
2/27/2024
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuyC$13.00
1/19/2024
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperformC$18.00 ➝ C$14.50
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.56N/AN/A$2.97 per share0.39
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
C$1.26B2.02N/AN/AC$10.19 per share1.21

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
C$367.68MC$1.657.440.5929.12%18.16%10.71%5/14/2024 (Estimated)

Latest NVA, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/29/2024Q4 2023
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
C$0.49C$0.41-C$0.08C$0.41C$364.00 millionC$365.50 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
N/AN/AN/AN/AN/A

Latest NVA, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
14.42
1.04
0.78

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
24.73%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
22.89%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
NuVista Energy Ltd. stock logo
NVA
NuVista Energy
88207.58 millionN/ANot Optionable

NVA, BOLT, CZX, and FCR Headlines

SourceHeadline
Thursday’s Insider Report: Large shareholder unloads $75-million in this energy stockThursday’s Insider Report: Large shareholder unloads $75-million in this energy stock
theglobeandmail.com - April 18 at 7:28 AM
Paramount Resources Ltd. Sells 6,000,000 Shares of NuVista Energy Ltd. (TSE:NVA) StockParamount Resources Ltd. Sells 6,000,000 Shares of NuVista Energy Ltd. (TSE:NVA) Stock
americanbankingnews.com - April 14 at 4:04 AM
NuVista Energy Ltd. (TSE:NVA) Insider Sells C$75,000,000.00 in StockNuVista Energy Ltd. (TSE:NVA) Insider Sells C$75,000,000.00 in Stock
insidertrades.com - April 13 at 6:50 AM
NuVista Energy (TSE:NVA) Given a C$17.00 Price Target at BMO Capital MarketsNuVista Energy (TSE:NVA) Given a C$17.00 Price Target at BMO Capital Markets
americanbankingnews.com - April 10 at 3:16 AM
Canadian energy producers say they are prepared for 2024 drought, wildfire risksCanadian energy producers say they are prepared for 2024 drought, wildfire risks
msn.com - April 9 at 2:44 PM
NuVista Energy (TSE:NVA) Given a C$17.00 Price Target by BMO Capital Markets AnalystsNuVista Energy (TSE:NVA) Given a C$17.00 Price Target by BMO Capital Markets Analysts
marketbeat.com - April 9 at 2:16 PM
NuVista Energy Ltd. (TSE:NVA) Given Average Recommendation of "Moderate Buy" by AnalystsNuVista Energy Ltd. (TSE:NVA) Given Average Recommendation of "Moderate Buy" by Analysts
americanbankingnews.com - April 8 at 4:18 AM
NuVista Energy Ltd. (TSE:NVA) Receives Average Recommendation of "Moderate Buy" from BrokeragesNuVista Energy Ltd. (TSE:NVA) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - April 8 at 4:13 AM
NuVista Energy (TSE:NVA) Price Target Cut to C$14.75NuVista Energy (TSE:NVA) Price Target Cut to C$14.75
marketbeat.com - March 22 at 2:31 PM
NVA Makes Bullish Cross Above Critical Moving AverageNVA Makes Bullish Cross Above Critical Moving Average
nasdaq.com - March 21 at 4:38 PM
NVA:CA NuVista Energy Ltd.NVA:CA NuVista Energy Ltd.
seekingalpha.com - March 19 at 8:42 AM
NuVista Energy Full Year 2023 Earnings: Misses ExpectationsNuVista Energy Full Year 2023 Earnings: Misses Expectations
finance.yahoo.com - March 2 at 8:26 AM
Canadian Market Modestly Higher On Results, Economic DataCanadian Market Modestly Higher On Results, Economic Data
markets.businessinsider.com - February 29 at 12:35 PM
TSX Ends Slightly Weak Ahead Of BoC Rate DecisionTSX Ends Slightly Weak Ahead Of BoC Rate Decision
markets.businessinsider.com - December 5 at 5:55 PM
NuVista Energy Ltd NVANuVista Energy Ltd NVA
morningstar.com - November 9 at 2:14 AM
NuVista Energy Tightens 2023 Production Guidance, Eyes Growth Ahead -- Energy CommentNuVista Energy Tightens 2023 Production Guidance, Eyes Growth Ahead -- Energy Comment
marketwatch.com - November 8 at 10:33 AM
Closing Bell: Nuvista Energy Ltd flat on Wednesday (NVA)Closing Bell: Nuvista Energy Ltd flat on Wednesday (NVA)
theglobeandmail.com - September 6 at 7:10 PM
CIBC CAPITAL MARKETS Maintains NuVista Energy (TSX:NVA) Outperform RecommendationCIBC CAPITAL MARKETS Maintains NuVista Energy (TSX:NVA) Outperform Recommendation
nasdaq.com - September 1 at 12:43 AM
NuVista renews normal course issuer bidNuVista renews normal course issuer bid
seekingalpha.com - June 14 at 8:02 AM
NuVista Receives TSX Approval for the Renewal of its Normal Course Issuer BidNuVista Receives TSX Approval for the Renewal of its Normal Course Issuer Bid
finance.yahoo.com - June 14 at 8:02 AM
NuVista Energy Ltd. Provides Update on Wildfires and Production GuidanceNuVista Energy Ltd. Provides Update on Wildfires and Production Guidance
finance.yahoo.com - June 5 at 7:47 PM
NuVista restarts most of its operations as wildfire concerns easeNuVista restarts most of its operations as wildfire concerns ease
ca.finance.yahoo.com - May 23 at 1:14 PM
NuVista Energy restarts most of its operations as wildfire concerns in Alberta easeNuVista Energy restarts most of its operations as wildfire concerns in Alberta ease
theglobeandmail.com - May 23 at 1:14 PM
NuVista Energy Ltd. Provides Update on Wildfire Impact in Grande Prairie OperationsNuVista Energy Ltd. Provides Update on Wildfire Impact in Grande Prairie Operations
finance.yahoo.com - May 23 at 8:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
NuVista Energy logo

NuVista Energy

TSE:NVA
NuVista Energy Ltd., together with its subsidiary, engages in the exploration, development, and production of oil and natural gas reserves in the Western Canadian Sedimentary Basin. The company is involved in the development, delineation, and production of condensate, natural gas liquids, and natural gas reserves. It primarily focuses on the condensate rich Montney formation in the Pipestone and Wapiti areas of the Alberta Deep Basin. The company was incorporated in 2003 and is headquartered in Calgary, Canada.